跳至主要内容
临床试验/NCT02519751
NCT02519751已完成不适用

Total Body Skeletal Muscle Mass Estimation by Creatine (Methyl-d3) Dilution in Athletes

GlaxoSmithKline2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2014年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
2
主要终点
Correlation between muscle mass obtained by MRI method and D3-Creatine method

研究概览

简要总结

Creatine (methyl-d3) dilution (D3-creatine) is a novel technique for the estimation of muscle mass. The method uses a dose of deuterium-labelled creatine to determine total skeletal muscle mass via estimation of total body creatine pool size.The aim of this study is to compare estimates of total body skeletal muscle mass by D3-creatine dilution method and whole body Magnetic Resonance Imaging (MRI) in an athletic population.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Trained and competing elite canoe athletes will be recruited, who represent Great Britain Canoeing

排除标准

  • Pregnant and lactating women
  • Intolerance or hypersensitivity to Creatine supplementation
  • Athletes with disabilities which affect their total body muscle mass
  • If creatine was taken in a supplemented form, rather than dietary intake, more regularly than once a week within 6-weeks of assessment commencing
  • Contraindication to an MRI scan

结局指标

主要结局

Correlation between muscle mass obtained by MRI method and D3-Creatine method

时间窗: Upto 3 months

MRI scan of the participants will be done at Day 1 and end of study (i.e.Day 90).D3-Creatine capsule will be given orally at Day 1 and urine samples collected at 0-4h and 4-24h every day from Day 1 to Day 4.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

New Method Using Deuterium Labelled Creatine to... | 临床试验